New York City Actos Lawsuit Attorney
Actos is a prescription drug, often used in tandem with insulin, that lowers blood sugar levels in those suffering from Type 2 diabetes. Since it was approved by the Food & Drug Administration in 1999, the drug has been used by millions of people and made billions of dollars for its manufacturer, Takeda Pharmaceutical Company.
However, just a few years after the drug hit the market, problems began to appear. By 2004, the company’s internal studies were revealing that the drug increased the risk of bladder cancer, and doctors were beginning to connect the dots.
By 2015, the FDA had released a warning about the drug’s link to bladder cancer, and Takeda had agreed to pay out billions of dollars in compensation for their defective drug and misleading advertising.
Contacting a New York City Actos lawyer can potentially allow you to recover money for pain and suffering after using a defective drug that you were prescribed.
Actos Fast Facts
Generic name: Pioglitazone
Uses: Type 2 Diabetes
Treatments for: High blood sugar
Possible side effects: Bone fractures, fluid retention, congestive heart failure, cardiac events, anemia, bladder cancer and bladder tumors.
FDA Approval: 1999
Manufacturer: Takeda Pharmaceutical Company (Japan)
Actos Defective Drug Timeline
1999: The drug is approved for sale in the United States by the FDA.
2004: The first study shows a link between Actos and bladder cancer, but the information is not clearly published until 2009.
2011: The American Diabetes Association (ADA) publishes a report based on FDA database information that clearly shows that taking Actos will increase your risk of bladder tumors.
2011: Actos is banned in France and Germany.
2011: The FDA announces “that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” It also issues a black box warning for the drug.
2012: A study published in the British Medical Journal finds that taking Actos more than doubles a person’s chances of developing bladder cancer. Many more studies follow.
2014: A Louisiana jury awarded an Actos cancer plaintiff $9 billion.
2015: Takeda agrees to pay out $2.4 billion in damages in an effort to settle most Actos cases. Over 8,000 cases are settled.
2016-present day: Actos lawsuits continue.
2015 Actos Lawsuit Settlement
In April 2015, Takeda agreed to settle a large number of Actos bladder cancer cases for a total of $2.4 billion. The average payment to affected families was $250,000, with some families receiving more compensation – for example, for wrongful death – and some families receiving less – for example, if the victim smoked cigarettes.
Our New York City Actos Lawyers Can Help With Your Product Liability Case
It is not too late to file your Actos bladder cancer lawsuit.
Pharmaceutical companies have a duty under the law to warn consumers about the health risks associated with the drugs they manufacture and sell. If you believe that the makers of Actos violated this duty and that the result of that violation was bladder cancer, Takeda Pharmaceutical Company might owe you compensation for your losses, including:
- Past and future medical bills
- Lost wages and future lost wages
- Permanent disabilities
- Pain and suffering
Stand up against Big Pharma and make certain that no one else is harmed by Actos in the future. Contact Meirowitz & Wasserberg today to tell your story and learn about your best options for legal action. To ask our product liability attorneys a question, learn more about our legal services, or request a free consultation, please contact our offices by calling 212-897-1988 or filling out our short contact form.